500
Participants
Start Date
May 21, 2021
Primary Completion Date
November 29, 2021
Study Completion Date
December 31, 2021
ARNA Breast
Women of the required age group, in case of suspicion of breast cancer, are sent to clarify the diagnosis for mammography or ultrasound of the mammary glands, or MRI. Based on the results of these studies, a biopsy is prescribed to make a final diagnosis. Before a biopsy to diagnose the presence / absence of breast cancer, patients do the blood sampling one time. The blood is processed in the Sponsor's laboratory. The test results are compared with the data obtained from the biopsy. The evaluation of the effectiveness of the method will be determined on the basis of the obtained data on the sensitivity and specificity of the test in relation to the reference method
Lead Sponsor
BIOMARKER-RU
UNKNOWN
ARNA Genomics US Inc.
INDUSTRY